EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Future of Dialysis and Kidney Xenotransplantation: Promise, Cost, and Barriers to Implementation

Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Stefano Stuard iD

Journal of Clinical Medicine · 30.10.2026 · 15 (21) · 8464

DOI: 10.3390/jcm15218464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.10.2026. Verfasst von Carmine Zoccali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, NY 10065, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Dialysis remains essential for patients with kidney failure but replaces only part of kidney function and imposes a substantial treatment burden. Gene-edited porcine kidneys offer a possible additional source of organs, although clinical experience remains limited. This review examines advances in dialysis and kidney xenotransplantation, their evidence base, costs, and barriers to clinical use.

Methods

We undertook a targeted narrative update of clinical and technological reports, economic studies, and regulatory material. Randomized trials were considered separately from observational studies, target trial emulations, individual cases, preclinical experiments, and economic projections.

Results

Randomized evidence supports a survival benefit of high-volume hemodiafiltration in suitable patients, although individual trials have differed and achieved convection volume is influenced by patient and treatment characteristics. Wearable dialysis and sorbent-assisted peritoneal dialysis remain at an early stage of clinical evaluation. Porcine kidney xenografts have provided dialysis independence in individual recipients, but rejection, endothelial injury, infection, and the burden of immunosuppression remain unresolved. Human kidney transplantation is generally favorable over longer horizons in eligible patients; its value depends on the setting. Xenotransplantation costs and long-term cost-effectiveness remain uncertain. Implementation requires financing, trained staff, reliable supply chains, and informed consent that addresses prolonged surveillance and cultural concerns.

Conclusions

Improved dialysis and kidney xenotransplantation are likely to have complementary roles. Adoption should depend on demonstrated clinical benefit, sustainable costs, and equitable access, while prevention and early treatment of chronic kidney disease remain priorities.

Schlagwörter

Stichwörter der Autor:innen

end-stage kidney diseasehealth economics and implementation barriershemodiafiltrationhemodialysismedium cut-off membranesperitoneal dialysisporcine kidney xenotransplantationprecision dialysiswearable artificial kidney

Autor:innen und Institutionen

  • Renal Research Institute, New York, NY 10065, USA.
  • Istituto di Biologia e Genetica Molecolare (BIOGEM), 83031 Ariano Irpino, Italy.
  • Associazione Ipertensione Nefrologia e Trapianto Renale (IPNET), 89124 Reggio Calabria, Italy.
  • National Research Council-Institute of Clinical Physiology, 89124 Reggio Calabria, Italy.
  • Global Medical Office, Fresenius Medical Care, 26010 Palazzo Pignano, Italy.

ORCID-Profile: Stefano Stuard

Zitieren

APA

Zoccali, C., Mallamaci, F., Tripepi, G., & Stuard, S. (2026). The Future of Dialysis and Kidney Xenotransplantation: Promise, Cost, and Barriers to Implementation. Journal of Clinical Medicine, 15(21), 8464. https://doi.org/10.3390/jcm15218464

Vancouver

Zoccali C, Mallamaci F, Tripepi G, Stuard S. The Future of Dialysis and Kidney Xenotransplantation: Promise, Cost, and Barriers to Implementation. Journal of Clinical Medicine. 2026;15(21):8464. doi:10.3390/jcm15218464

BibTeX
@article{Zoccali2026,
  author = {Zoccali, Carmine and Mallamaci, Francesca and Tripepi, Giovanni and Stuard, Stefano},
  title = {The Future of Dialysis and Kidney Xenotransplantation: Promise, Cost, and Barriers to Implementation},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8464},
  doi = {10.3390/jcm15218464}
}
Kostenlos starten →